Clinical Trial Update: Phase 2 Study of TXA127 in Post-ischemic Stroke Patients [Phase 2]

View source ↗

Summary

Phase 2 study update for TXA127 in ischemic stroke patients is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• TXA127

Snippet

Sponsor: Constant Therapeutics LLC | Conditions: Ischemic Stroke | Phase 2 | Status: UNKNOWN